Health assessments conducted at home are becoming more and more popular. At-home pregnancy tests hit the market 45 years ago, now we have cholesterol, HIV and many more tests that can be performed from the comfort of your home. A sign that the at-home-health trend is not letting up, executives at Twitter and EventBrite invested in a new Silicon Valley start-up playing in this very space called Color Genomics. The company is making cancer screenings available to the masses and for a much cheaper price than we see in the marketplace today. Their product? A $249-mail in saliva test kit that checks for variants in 19 genes known to be correlated with a higher risk of breast or ovarian cancer. The test is available now and you can view your results online.

Check out the video below.